Study
Measuring minimal residual disease in acute myeloid leukemia with MASQ
| Study ID | Alternative Stable ID | Type |
|---|---|---|
| EGAS00001003732 | Cancer Genomics |
Study Description
Study Datasets 2 datasets.
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
| Dataset ID | Description | Technology | Samples |
|---|---|---|---|
| EGAD00001005120 |
Whole genome sequencing of AML blood or bone marrow at presentation and remission for 5 patients. Relapse samples are included for 2 patients, totaling 12 WGS BAM files.
|
NextSeq 500 | 12 |
| EGAD00001005121 |
MASQ targeted amplicon sequencing of AML blood or bone marrow at presentation, and relapse, when available, for 5 patients. Remission samples of both blood and bone marrow are included for 5 patients. Multiple batches (b1,b2) are used for 2 patients. There are 25 assays of AML data. MASQ data demonstrating sensitivity, input range, and batch size are also included, as 12 assays. All data is provided in paired FASTQ files.
|
NextSeq 500 | 37 |
Who archives the data?
Publications
Citations
Retrieving...
Retrieving...
